Mesoblast Limited (MESO) Cut to Sell at ValuEngine
Mesoblast Limited (NASDAQ:MESO) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Friday.
Other equities research analysts have also issued reports about the stock. CIBC began coverage on shares of Mesoblast Limited in a report on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective for the company. Maxim Group set a $14.00 price objective on shares of Mesoblast Limited and gave the company a “buy” rating in a report on Wednesday, August 16th. Zacks Investment Research raised shares of Mesoblast Limited from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $20.00 price objective on shares of Mesoblast Limited in a report on Wednesday, August 30th. Finally, BidaskClub lowered shares of Mesoblast Limited from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $13.64.
Shares of Mesoblast Limited (NASDAQ MESO) traded down 0.90% during midday trading on Friday, reaching $5.50. 15,657 shares of the company’s stock traded hands. The firm’s market capitalization is $467.19 million. The stock’s 50-day moving average price is $6.55 and its 200 day moving average price is $8.22. Mesoblast Limited has a one year low of $4.01 and a one year high of $12.50.
A hedge fund recently raised its stake in Mesoblast Limited stock. Princeton Capital Management Inc. increased its stake in Mesoblast Limited (NASDAQ:MESO) by 15.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the quarter. Princeton Capital Management Inc. owned about 0.20% of Mesoblast Limited worth $1,398,000 as of its most recent SEC filing. Institutional investors own 2.95% of the company’s stock.
About Mesoblast Limited
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with MarketBeat.com's FREE daily email newsletter.